The lipoxygenase pathway and tracheal muscle contraction.
D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology; D000818:Animals; D006632:Histamine / Q000494:pharmacology*; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D016859:Lipoxygenase Inhibitors; D009119:Muscle Contraction / Q000187:drug effects*; D011720:Pyrazoles / Q000494:pharmacology; D013552:Swine; D014132:Trachea / Q000187:drug effects / Q000502:physiology*
D016859:Lipoxygenase Inhibitors; D011720:Pyrazoles; D015117:5,8,11,14-Eicosatetraynoic Acid; D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D006632:Histamine; D007213:Indomethacin